Non-simian foamy viruses: Molecular virology, tropism and prevalence and zoonotic/interspecies transmission

Viruses

Volumn 5, Issue 9, 2013, Pages 2169-2209

  Kehl, Timo ^a   Tan, Juan ^b   Materniak, Magdalena ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NANKAI UNIVERSITY   (China)

^c NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

Animal FVs; Foamy virus; FV tropism; Interspecies transmission; Zoonotic potential

Indexed keywords

ELVITEGRAVIR; INTEGRASE; RALTEGRAVIR; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; ENZYME ACTIVITY; ENZYME CHEMISTRY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PROTEIN DNA INTERACTION; RETROVIRUS; REVIEW; SPUMA VIRUS; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION;

ANIMALS; HUMANS; PHYLOGENY; PREVALENCE; PRIMATE DISEASES; RETROVIRIDAE INFECTIONS; SPUMAVIRUS; VIRAL TROPISM; ZOONOSES;

EID: 84884177314     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5092169     Document Type: Review

References (209)

1. Saib, A. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277, 197-211.
2. Delelis, O.; Lehmann-Che, J.; Saib, A. Foamy viruses-A world apart. Curr. Opin. Microbiol. 2004, 7, 400-406.
3. Murray, S.M.; Linial, M.L. Foamy virus infection in primates. J. Med. Primatol. 2006, 35, 225-235.
4. Rethwilm, A. Molecular biology of foamy viruses. Med. Microbiol. Immunol. 2010, 199, 197-207.
5. Meiering, C.D.; Linial, M.L. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 2001, 14, 165-176.
6. Enders, J.F.; Peebles, T.C. Propagation in tissue culture of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 1954, 86, 277-286.
7. Achong, B.G.; Mansell, P.W.; Epstein, M.A.; Clifford, P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Canc. Inst. 1971, 46, 299-307.
8. Herchenroder, O.; Renne, R.; Loncar, D.; Cobb, E.K.; Murthy, K.K.; Schneider, J.; Mergia, A.; Luciw, P.A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (sfvcpz): High homology to human foamy virus (hfv). Virology 1994, 201, 187-199.
9. Switzer, W.M.; Bhullar, V.; Shanmugam, V.; Cong, M.E.; Parekh, B.; Lerche, N.W.; Yee, J.L.; Ely, J.J.; Boneva, R.; Chapman, L.E.; et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 2004, 78, 2780-2789.
10. Schulze, A.; Lemey, P.; Schubert, J.; McClure, M.O.; Rethwilm, A.; Bodem, J. Complete nucleotide sequence and evolutionary analysis of a gorilla foamy virus. J. Gen. Virol. 2011, 92, 582-586.
11. Switzer, W.M.; Salemi, M.; Shanmugam, V.; Gao, F.; Cong, M.E.; Kuiken, C.; Bhullar, V.; Beer, B.E.; Vallet, D.; Gautier-Hion, A.; et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005, 434, 376-380.
12. Katzourakis, A.; Gifford, R.J.; Tristem, M.; Gilbert, M.T.; Pybus, O.G. Macroevolution of complex retroviruses. Science 2009, 325, 1512.
13. Han, G.Z.; Worobey, M. An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog. 2012, 8, e1002790.
14. Wu, Z.; Ren, X.; Yang, L.; Hu, Y.; Yang, J.; He, G.; Zhang, J.; Dong, J.; Sun, L.; Du, J.; et al. Virome analysis for identification of novel mammalian viruses in bat species from chinese provinces. J. Virol. 2012, 86, 10999-11012.
15. Han, G.Z.; Worobey, M. An endogenous foamy virus in the aye-aye (daubentonia madagascariensis). J. Virol. 2012, 86, 7696-7698.
16. Linial, M. Why aren't foamy viruses pathogenic? Trends Microbiol. 2000, 8, 284-289.
17. Wilk, T.; Geiselhart, V.; Frech, M.; Fuller, S.D.; Flugel, R.M.; Lochelt, M. Specific interaction of a novel foamy virus env leader protein with the n-terminal gag domain. J. Virol. 2001, 75, 7995-8007.
18. Kennedy-Stoskopf, S.; Stoskopf, M.K.; Eckhaus, M.A.; Strandberg, J.D. Isolation of a retrovirus and a herpesvirus from a captive california sea lion. J. Wildl. Dis. 1986, 22, 156-164.
19. Flanagan, M. Isolation of a spumavirus from a sheep. Aust. Vet. J. 1992, 69.
20. Materniak, M.; Kuzmak, J.; Olech, M. Seroreactivity to bovine foamy virus antigens in wild ruminants-Evidence for new reservoirs of foamy viruses. In Proceedings of XIII DIAGMOL Conference, Warsaw, Poland, 24 November 2012.
21. Hruska, J.F.; Takemoto, K.K. Biochemical properties of a hamster syncytium-forming ("foamy") virus. J. Natl. Canc. Inst. 1975, 54, 601-605.
22. McClure, M.O.; Bieniasz, P.D.; Schulz, T.F.; Chrystie, I.L.; Simpson, G.; Aguzzi, A.; Hoad, J.G.; Cunningham, A.; Kirkwood, J.; Weiss, R.A. Isolation of a new foamy retrovirus from orangutans. J. Virol. 1994, 68, 7124-7130.
23. Pacheco, B.; Finzi, A.; McGee-Estrada, K.; Sodroski, J. Species-specific inhibition of foamy viruses from south american monkeys by new world monkey trim5{alpha} proteins. J. Virol. 2010, 84, 4095-4099.
24. Renne, R.; Friedl, E.; Schweizer, M.; Fleps, U.; Turek, R.; Neumann-Haefelin, D. Genomic organization and expression of simian foamy virus type 3 (sfv-3). Virology 1992, 186, 597-608.
25. Thumer, L.; Rethwilm, A.; Holmes, E.C.; Bodem, J. The complete nucleotide sequence of a new world simian foamy virus. Virology 2007, 369, 191-197.
26. Verschoor, E.J.; Langenhuijzen, S.; van den Engel, S.; Niphuis, H.; Warren, K.S.; Heeney, J.L. Structural and evolutionary analysis of an orangutan foamy virus. J. Virol. 2003, 77, 8584-8587.
27. Bodem, J.; Lochelt, M.; Winkler, I.; Flower, R.P.; Delius, H.; Flugel, R.M. Characterization of the spliced pol transcript of feline foamy virus: The splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 1996, 70, 9024-9027.
28. Winkler, I.; Bodem, J.; Haas, L.; Zemba, M.; Delius, H.; Flower, R.; Flugel, R.M.; Lochelt, M. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 1997, 71, 6727-6741.
29. Kehl, T.; Bleiholder, A.; Rossmann, F.; Rupp, S.; Lei, J.; Lee, J.; Boyce, W.M.; Vickers, W.; Crooks, K.; VandeWoude, S.; Loechelt, M. Complete genome sequences of two novel puma concolor foamy viruses from California. Genome Announc. 2013, 1, e00201-12.
30. Materniak, M.; Bicka, L.; Kuzmak, J. Isolation and partial characterization of bovine foamy virus from polish cattle. Pol. J. Vet. Sci. 2006, 9, 207-211.
31. Hechler, T.; Materniak, M.; Kehl, T.; Kuzmak, J.; Lochelt, M. Complete genome sequences of two novel european clade bovine foamy viruses from germany and poland. J. Virol. 2012, 86, 10905-10906.
32. Holzschu, D.L.; Delaney, M.A.; Renshaw, R.W.; Casey, J.W. The nucleotide sequence and spliced pol mrna levels of the nonprimate spumavirus bovine foamy virus. J. Virol. 1998, 72, 2177-2182.
33. Tobaly-Tapiero, J.; Bittoun, P.; Neves, M.; Guillemin, M.C.; Lecellier, C.H.; Puvion-Dutilleul, F.; Gicquel, B.; Zientara, S.; Giron, M.L.; de The, H.; et al. Isolation and characterization of an equine foamy virus. J. Virol. 2000, 74, 4064-4073.
34. Phung, H.T.; Ikeda, Y.; Miyazawa, T.; Nakamura, K.; Mochizuki, M.; Izumiya, Y.; Sato, E.; Nishimura, Y.; Tohya, Y.; Takahashi, E.; et al. Genetic analyses of feline foamy virus isolates from domestic and wild feline species in geographically distinct areas. Virus Res. 2001, 76, 171-181.
35. Flower, R.L.; Wilcox, G.E.; Cook, R.D.; Ellis, T.M. Detection and prevalence of serotypes of feline syncytial spumaviruses. Arch. Virol. 1985, 83, 53-63.
36. Hackett, A.J.; Manning, J.S. Comments on feline syncytia-forming virus. J. Am. Vet. Med. Assoc. 1971, 158, 948+.
37. Helps, C.R.; Harbour, D.A. Comparison of the complete sequence of feline spumavirus with those of the primate spumaviruses reveals a shorter gag gene. J. Gen. Virol. 1997, 78, 2549-2564.
38. Winkler, I.G.; Flugel, R.M.; Lochelt, M.; Flower, R.L. Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology 1998, 247, 144-151.
39. Zemba, M.; Alke, A.; Bodem, J.; Winkler, I.G.; Flower, R.L.; Pfrepper, K.; Delius, H.; Flugel, R.M.; Lochelt, M. Construction of infectious feline foamy virus genomes: Cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific env sequences. Virology 2000, 266, 150-156.
40. Löchelt, M. DKFZ, Heidelberg, Baden-Württemberg, Germany. Personal communication, 2013.
41. Johnson, W.E.; Eizirik, E.; Pecon-Slattery, J.; Murphy, W.J.; Antunes, A.; Teeling, E.; O'Brien, S.J. The late miocene radiation of modern felidae: A genetic assessment. Science 2006, 311, 73-77.
42. O'Brien, S.J.; Johnson, W.E. Big cat genomics. Annu. Rev. Genom. Hum. Genet. 2005, 6, 407-429.
43. O'Brien, S.J.; Johnson, W.E. The evolution of cats. Genomic paw prints in the DNA of the world's wild cats have clarified the cat family tree and uncovered several remarkable migrations in their past. Sci. Am. 2007, 297, 68-75.
44. Biomatters Geneious, 6.05; Biomatters Ltd: New Zealand, 2013.
45. Heads, M. Evolution and biogeography of primates: A new model based on molecular phylogenetics, vicariance and plate tectonics. Zoolog. Scripta 2010, 39, 107-127.
46. Bastone, P.; Truyen, U.; Lochelt, M. Potential of zoonotic transmission of non-primate foamy viruses to humans. J. Vet. Med. B 2003, 50, 417-423.
47. Calattini, S.; Betsem, E.B.; Froment, A.; Mauclere, P.; Tortevoye, P.; Schmitt, C.; Njouom, R.; Saib, A.; Gessain, A. Simian foamy virus transmission from apes to humans, rural cameroon. Emerg. Infect. Dis. 2007, 13, 1314-1320.
48. Murphy, H.W.; Miller, M.; Ramer, J.; Travis, D.; Barbiers, R.; Wolfe, N.D.; Switzer, W.M. Implications of simian retroviruses for captive primate population management and the occupational safety of primate handlers. J. Zoo Wildl. Med. 2006, 37, 219-233.
49. Locatelli, S.; Peeters, M. Cross-species transmission of simian retroviruses: How and why they could lead to the emergence of new diseases in the human population. Aids 2012, 26, 659-673.
50. Campbell, M.; Renshaw-Gegg, L.; Renne, R.; Luciw, P.A. Characterization of the internal promoter of simian foamy viruses. J. Virol. 1994, 68, 4811-4820.
51. Lochelt, M.; Flugel, R.M.; Aboud, M. The human foamy virus internal promoter directs the expression of the functional bel 1 transactivator and bet protein early after infection. J. Virol. 1994, 68, 638-645.
52. Lochelt, M. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 2003, 277, 27-61.
53. Bailey, T.L.; Boden, M.; Buske, F.A.; Frith, M.; Grant, C.E.; Clementi, L.; Ren, J.; Li, W.W.; Noble, W.S. Meme suite: Tools for motif discovery and searching. Nucleic Acids Res. 2009, 37, W202-W208.
54. Lochelt, M.; Muranyi, W.; Flugel, R.M. Human foamy virus genome possesses an internal, bel-1-dependent and functional promoter. Proc. Natl. Acad. Sci. USA 1993, 90, 7317-7321.
55. Pfrepper, K.I.; Lochelt, M.; Rackwitz, H.R.; Schnolzer, M.; Heid, H.; Flugel, R.M. Molecular characterization of proteolytic processing of the gag proteins of human spumavirus. J. Virol. 1999, 73, 7907-7911.
56. Enssle, J.; Fischer, N.; Moebes, A.; Mauer, B.; Smola, U.; Rethwilm, A. Carboxy-terminal cleavage of the human foamy virus gag precursor molecule is an essential step in the viral life cycle. J. Virol. 1997, 71, 7312-7317.
57. Eastman, S.W.; Linial, M.L. Identification of a conserved residue of foamy virus gag required for intracellular capsid assembly. J. Virol. 2001, 75, 6857-6864.
58. Lindemann, D.; Pietschmann, T.; Picard-Maureau, M.; Berg, A.; Heinkelein, M.; Thurow, J.; Knaus, P.; Zentgraf, H.; Rethwilm, A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 2001, 75, 5762-5771.
59. Geiselhart, V.; Bastone, P.; Kempf, T.; Schnolzer, M.; Lochelt, M. Furin-mediated cleavage of the feline foamy virus env leader protein. J. Virol. 2004, 78, 13573-13581.
60. Henikoff, S.; Henikoff, J.G. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA 1992, 89, 10915-10919.
61. Needleman, S.B.; Wunsch, C.D. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 1970, 48, 443-453.
62. Thomas, G. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nature reviews. Molecular cell biology 2002, 3, 753-766.
63. Linial, M.L. Foamy viruses are unconventional retroviruses. J. Virol. 1999, 73, 1747-1755.
64. Sa-Nguanmoo, P.; Rianthavorn, P.; Amornsawadwattana, S.; Poovorawan, Y. Hepatitis b virus infection in non-human primates. Acta Virol. 2009, 53, 73-82.
65. Rethwilm, A. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277, 1-26.
66. Roy, J.; Rudolph, W.; Juretzek, T.; Gartner, K.; Bock, M.; Herchenroder, O.; Lindemann, D.; Heinkelein, M.; Rethwilm, A. Feline foamy virus genome and replication strategy. J. Virol. 2003, 77, 11324-11331.
67. Clarke, J.K.; Attridge, J.T. The morphology of simian foamy agents. J. Gen. Virol. 1968, 3, 185-190.
68. Clarke, J.K.; Attridge, J.T.; Gay, F.W. The morphogenesis of simian foamy agents. J. Gen. Virol. 1969, 4, 183-188.
69. Dermott, E.; Clarke, J.K.; Samuels, J. The morphogenesis and classification of bovine syncytial virus. J. Gen. Virol. 1971, 12, 105-119.
70. Riggs, J.L.; Oshiro, L.S.; Taylor, D.O.N.; Lennette, E.H. Syncytium-forming agent isolated from domestic cats. Nature 1969, 222, 1190-1191.
71. Flugel, R.M.; Pfrepper, K.I. Proteolytic processing of foamy virus gag and pol proteins. Curr. Top. Microbiol. Immunol. 2003, 277, 63-88.
72. Fischer, N.; Heinkelein, M.; Lindemann, D.; Enssle, J.; Baum, C.; Werder, E.; Zentgraf, H.; Muller, J.G.; Rethwilm, A. Foamy virus particle formation. J. Virol. 1998, 72, 1610-1615.
73. Morozov, V.A.; Copeland, T.D.; Nagashima, K.; Gonda, M.A.; Oroszlan, S. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology 1997, 228, 307-317.
74. Konvalinka, J.; Lochelt, M.; Zentgraf, H.; Flugel, R.M.; Krausslich, H.G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a pol polyprotein. J. Virol. 1995, 69, 7264-7268.
75. Zemba, M.; Wilk, T.; Rutten, T.; Wagner, A.; Flugel, R.M.; Lochelt, M. The carboxy-terminal p3gag domain of the human foamy virus gag precursor is required for efficient virus infectivity. Virology 1998, 247, 7-13.
76. Pincetic, A.; Leis, J. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009, 2009, 6239691-6239699.
77. Life, R.B.; Lee, E.G.; Eastman, S.W.; Linial, M.L. Mutations in the amino terminus of foamy virus gag disrupt morphology and infectivity but do not target assembly. J. Virol. 2008, 82, 6109-6119.
78. Duda, A.; Stange, A.; Luftenegger, D.; Stanke, N.; Westphal, D.; Pietschmann, T.; Eastman, S.W.; Linial, M.L.; Rethwilm, A.; Lindemann, D. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 2004, 78, 13865-13870.
79. Lindemann, D.; Goepfert, P.A. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 2003, 277, 111-129.
80. Stanke, N.; Stange, A.; Luftenegger, D.; Zentgraf, H.; Lindemann, D. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J. Virol. 2005, 79, 15074-15083.
81. Stange, A.; Luftenegger, D.; Reh, J.; Weissenhorn, W.; Lindemann, D. Subviral particle release determinants of prototype foamy virus. J. Virol. 2008, 82, 9858-9869.
82. Löchelt, M.; Bleiholder, A.; Wirthschaft, P. DKFZ, Heidelberg, Baden-Württemberg, Germany. Personal communication, 2013.
83. Goepfert, P.A.; Shaw, K.L.; Ritter, G.D., Jr.; Mulligan, M.J. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J. Virol. 1997, 71, 778-784.
84. Goepfert, P.A.; Shaw, K.; Wang, G.; Bansal, A.; Edwards, B.H.; Mulligan, M.J. An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes. J. Virol. 1999, 73, 7210-7217.
85. Jackson, M.R.; Nilsson, T.; Peterson, P.A. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 1990, 9, 3153-3162.
86. Goepfert, P.A.; Wang, G.; Mulligan, M.J. Identification of an er retrieval signal in a retroviral glycoprotein. Cell 1995, 82, 543-544.
87. Kong, X.H.; Yu, H.; Xuan, C.H.; Wang, J.Z.; Chen, Q.M.; Geng, Y.Q. The requirements and mechanism for capsid assembly and budding of bovine foamy virus. Arch. Virol. 2005, 150, 1677-1684.
88. Lecellier, C.H.; Neves, M.; Giron, M.L.; Tobaly-Tapiero, J.; Saib, A. Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J. Virol. 2002, 76, 7220-7227.
89. Alke, A.; Schwantes, A.; Kido, K.; Flotenmeyer, M.; Flugel, R.M.; Lochelt, M. The bet gene of feline foamy virus is required for virus replication. Virology 2001, 287, 310-320.
90. Löchelt, M. DKFZ, Heidelberg, Baden-Württemberg, Germany. Unpublished work, 2010-2013.
91. He, F.; Blair, W.S.; Fukushima, J.; Cullen, B.R. The human foamy virus bel-1 transcription factor is a sequence-specific DNA binding protein. J. Virol. 1996, 70, 3902-3908.
92. Tan, J.; Hao, P.; Jia, R.; Yang, W.; Liu, R.; Wang, J.; Xi, Z.; Geng, Y.; Qiao, W. Identification and functional characterization of btas transactivator as a DNA-binding protein. Virology 2010, 405, 408-413.
93. Lochelt, M.; Aboud, M.; Flugel, R.M. Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res. 1993, 21, 4226-4230.
94. Meiering, C.D.; Rubio, C.; May, C.; Linial, M.L. Cell-type-specific regulation of the two foamy virus promoters. J. Virol. 2001, 75, 6547-6557.
95. Erlwein, O.; Rethwilm, A. Bel-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 1993, 196, 256-268.
96. Mergia, A.; Pratt-Lowe, E.; Shaw, K.E.; Renshaw-Gegg, L.W.; Luciw, P.A. Cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J. Virol. 1992, 66, 251-257.
97. Renne, R.; Mergia, A.; Renshaw-Gegg, L.W.; Neumann-Haefelin, D.; Luciw, P.A. Regulatory elements in the long terminal repeat (ltr) of simian foamy virus type 3 (sfv-3). Virology 1993, 192, 365-369.
98. Omoto, S.; Brisibe, E.A.; Okuyama, H.; Fujii, Y.R. Feline foamy virus tas protein is a DNAbinding transactivator. J. Gen. Virol. 2004, 85, 2931-2935.
99. Liu, J.; Wang, S.; Zhang, L.; Qiao, W.; Chen, Q.; Geng, Y. Functional analysis of bovine foamy virus accessory protein and borf-1 responsive elements in long terminal repeat. Chin. J. Virol. 2000, 16, 141-149.
100. Kang, Y.; Blair, W.S.; Cullen, B.R. Identification and functional characterization of a highaffinity bel-1 DNA binding site located in the human foamy virus internal promoter. J. Virol. 1998, 72, 504-511.
101. Zou, J.X.; Luciw, P.A. The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc. Natl. Acad. Sci. USA 1996, 93, 326-330.
102. Bodem, J.; Kang, Y.; Flugel, R.M. Comparative functional characterization of the feline foamy virus transactivator reveals its species specificity. Virology 2004, 318, 32-36.
103. Flugel, R.M.; Rethwilm, A.; Maurer, B.; Darai, G. Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J. 1987, 6, 2077-2084.
104. Mergia, A.; Shaw, K.E.; Pratt-Lowe, E.; Barry, P.A.; Luciw, P.A. Identification of the simian foamy virus transcriptional transactivator gene (taf). J. Virol. 1991, 65, 2903-2909.
105. He, F.; Sun, J.D.; Garrett, E.D.; Cullen, B.R. Functional organization of the bel-1 trans activator of human foamy virus. J. Virol. 1993, 67, 1896-1904.
106. Mergia, A.; Renshaw-Gegg, L.W.; Stout, M.W.; Renne, R.; Herchenroeder, O. Functional domains of the simian foamy virus type 1 transcriptional transactivator (taf). J. Virol. 1993, 67, 4598-4604.
107. Blair, W.S.; Bogerd, H.; Cullen, B.R. Genetic analysis indicates that the human foamy virus bel-1 protein contains a transcription activation domain of the acidic class. J. Virol. 1994, 68, 3803-3808.
108. Keller, A.; Partin, K.M.; Lochelt, M.; Bannert, H.; Flugel, R.M.; Cullen, B.R. Characterization of the transcriptional trans activator of human foamy retrovirus. J. Virol. 1991, 65, 2589-2594.
109. Lee, C.W.; Chang, J.; Lee, K.J.; Sung, Y.C. The bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids. J. Virol. 1994, 68, 2708-2719.
110. Tan, J.; Qiao, W.; Xu, F.; Han, H.; Chen, Q.; Geng, Y. Dimerization of btas is required for the transactivational activity of bovine foamy virus. Virology 2008, 376, 236-241.
111. Chang, J.; Lee, K.J.; Jang, K.L.; Lee, E.K.; Baek, G.H.; Sung, Y.C. Human foamy virus bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains. J. Virol. 1995, 69, 801-808.
112. Qiao, W.; Tan, J. College of Life Sciences, Nankai University, Tianjin, China. Unpublished work, 2012.
113. Bannert, H.; Muranyi, W.; Ogryzko, V.V.; Nakatani, Y.; Flugel, R.M. Coactivators p300 and pcaf physically and functionally interact with the foamy viral trans-activator. BMC Mol. Biol. 2004, 5, 16.
114. Bodem, J.; Krausslich, H.G.; Rethwilm, A. Acetylation of the foamy virus transactivator tas by pcaf augments promoter-binding affinity and virus transcription. J. Gen. Virol. 2007, 88, 259-263.
115. Chang, R.; Tan, J.; Xu, F.; Han, H.; Geng, Y.; Li, Y.; Qiao, W. Lysine acetylation sites in bovine foamy virus transactivator btas are important for its DNA binding activity. Virology 2011, 418, 21-26.
116. Wagner, A.; Doerks, A.; Aboud, M.; Alonso, A.; Tokino, T.; Flugel, R.M.; Lochelt, M. Induction of cellular genes is mediated by the bel1 transactivator in foamy virus-infected human cells. J. Virol. 2000, 74, 4441-4447.
117. Zheng, Y.H.; Jeang, K.T.; Tokunaga, K. Host restriction factors in retroviral infection: Promises in virus-host interaction. Retrovirology 2012, 9, 112.
118. Duggal, N.K.; Emerman, M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 2012, 12, 687-695.
119. Zielonka, J.; Munk, C. Cellular restriction factors of feline immunodeficiency virus. Viruses 2011, 3, 1986-2005.
120. Harris, R.S.; Hultquist, J.F.; Evans, D.T. The restriction factors of human immunodeficiency virus. J. Biol. Chem. 2012, 287, 40875-40883.
121. Zhang, C.; de Silva, S.; Wang, J.H.; Wu, L. Co-evolution of primate samhd1 and lentivirus vpx leads to the loss of the vpx gene in hiv-1 ancestor. PLoS One 2012, 7, e37477.
122. Chen, Z.; Zhang, L.; Ying, S. Samhd1: A novel antiviral factor in intrinsic immunity. Future Microbiol. 2012, 7, 1117-1126.
123. Holmes, R.K.; Malim, M.H.; Bishop, K.N. Apobec-mediated viral restriction: Not simply editing? Trends Biochem. Sci. 2007, 32, 118-128.
124. Zhang, J.; Ge, W.; Zhan, P.; De Clercq, E.; Liu, X. Retroviral restriction factors trim5alpha: Therapeutic strategy to inhibit hiv-1 replication. Curr. Med. Chem. 2011, 18, 2649-2654.
125. Kuhl, B.D.; Cheng, V.; Wainberg, M.A.; Liang, C. Tetherin and its viral antagonists. J. Neuroimmune Pharmacol. 2011, 6, 188-201.
126. Lilly, F. Susceptibility to two strains of friend leukemia virus in mice. Science 1967, 155, 461-462.
127. Laguette, N.; Benkirane, M. How samhd1 changes our view of viral restriction. Trends Immunol. 2012, 33, 26-33.
128. Sheehy, A.M.; Gaddis, N.C.; Choi, J.D.; Malim, M.H. Isolation of a human gene that inhibits hiv-1 infection and is suppressed by the viral vif protein. Nature 2002, 418, 646-650.
129. Yap, M.W.; Lindemann, D.; Stanke, N.; Reh, J.; Westphal, D.; Hanenberg, H.; Ohkura, S.; Stoye, J.P. Restriction of foamy viruses by primate trim5alpha. J. Virol. 2008, 82, 5429-5439.
130. Xu, F.; Tan, J.; Liu, R.; Xu, D.; Li, Y.; Geng, Y.; Liang, C.; Qiao, W. Tetherin inhibits prototypic foamy virus release. Virol. J. 2011, 8, 198.
131. Jouvenet, N.; Neil, S.J.; Zhadina, M.; Zang, T.; Kratovac, Z.; Lee, Y.; McNatt, M.; Hatziioannou, T.; Bieniasz, P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 83, 1837-1844.
132. Lochelt, M.; Romen, F.; Bastone, P.; Muckenfuss, H.; Kirchner, N.; Kim, Y.B.; Truyen, U.; Rosler, U.; Battenberg, M.; Saib, A.; et al. The antiretroviral activity of apobec3 is inhibited by the foamy virus accessory bet protein. Proc. Natl. Acad. Sci. USA 2005, 102, 7982-7987.
133. Russell, R.A.; Wiegand, H.L.; Moore, M.D.; Schafer, A.; McClure, M.O.; Cullen, B.R. Foamy virus bet proteins function as novel inhibitors of the apobec3 family of innate antiretroviral defense factors. J. Virol. 2005, 79, 8724-8731.
134. Munk, C.; Beck, T.; Zielonka, J.; Hotz-Wagenblatt, A.; Chareza, S.; Battenberg, M.; Thielebein, J.; Cichutek, K.; Bravo, I.G.; O'Brien, S.J.; et al. Functions, structure, and read-through alternative splicing of feline apobec3 genes. Genome Biol. 2008, 9, R48.
135. Delebecque, F.; Suspene, R.; Calattini, S.; Casartelli, N.; Saib, A.; Froment, A.; Wain-Hobson, S.; Gessain, A.; Vartanian, J.P.; Schwartz, O. Restriction of foamy viruses by apobec cytidine deaminases. J. Virol. 2006, 80, 605-614.
136. Bransteitter, R.; Prochnow, C.; Chen, X.S. The current structural and functional understanding of apobec deaminases. Cell. Mol. Life Sci. 2009, 66, 3137-3147.
137. Smith, H.C.; Bennett, R.P.; Kizilyer, A.; McDougall, W.M.; Prohaska, K.M. Functions and regulation of the apobec family of proteins. Semin. Cell Dev. Biol. 2012, 23, 258-268.
138. Vartanian, J.P.; Guetard, D.; Henry, M.; Wain-Hobson, S. Evidence for editing of human papillomavirus DNA by apobec3 in benign and precancerous lesions. Science 2008, 320, 230-233.
139. Turelli, P.; Mangeat, B.; Jost, S.; Vianin, S.; Trono, D. Inhibition of hepatitis b virus replication by apobec3g. Science 2004, 303, 1829.
140. Chareza, S.; Slavkovic Lukic, D.; Liu, Y.; Rathe, A.M.; Munk, C.; Zabogli, E.; Pistello, M.; Lochelt, M. Molecular and functional interactions of cat apobec3 and feline foamy and immunodeficiency virus proteins: Different ways to counteract host-encoded restriction. Virology 2012, 424, 138-146.
141. Schafer, A.; Bogerd, H.P.; Cullen, B.R. Specific packaging of apobec3g into hiv-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology 2004, 328, 163-168.
142. Perkovic, M.; Schmidt, S.; Marino, D.; Russell, R.A.; Stauch, B.; Hofmann, H.; Kopietz, F.; Kloke, B.P.; Zielonka, J.; Strover, H.; et al. Species-specific inhibition of apobec3c by the prototype foamy virus protein bet. J. Biol. Chem. 2009, 284, 5819-5826.
143. Wissing, S.; Galloway, N.L.; Greene, W.C. Hiv-1 vif versus the apobec3 cytidine deaminases: An intracellular duel between pathogen and host restriction factors. Mol. Aspect. Med. 2010, 31, 383-397.
144. Mariani, R.; Chen, D.; Schrofelbauer, B.; Navarro, F.; Konig, R.; Bollman, B.; Munk, C.; Nymark-McMahon, H.; Landau, N.R. Species-specific exclusion of apobec3g from hiv-1 virions by vif. Cell 2003, 114, 21-31.
145. Romen, F.; Pawlita, M.; Sehr, P.; Bachmann, S.; Schroder, J.; Lutz, H.; Lochelt, M. Antibodies against gag are diagnostic markers for feline foamy virus infections while env and bet reactivity is undetectable in a substantial fraction of infected cats. Virology 2006, 345, 502-508.
146. Munk, C.; Willemsen, A.; Bravo, I.G. An ancient history of gene duplications, fusions and losses in the evolution of apobec3 mutators in mammals. BMC Evol. Biol. 2012, 12, 71.
147. Hill, C.L.; Bieniasz, P.D.; McClure, M.O. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 1999, 80, 2003-2009.
148. Mergia, A.; Leung, N.J.; Blackwell, J. Cell tropism of the simian foamy virus type 1 (sfv-1). J. Med. Primatol. 1996, 25, 2-7.
149. Phung, H.T.; Tohya, Y.; Shimojima, M.; Kato, K.; Miyazawa, T.; Akashi, H. Establishment of a gfp-based indicator cell line to quantitate feline foamy virus. J. Virol. Meth. 2003, 109, 125-131.
150. Mikovits, J.A.; Hoffman, P.M.; Rethwilm, A.; Ruscetti, F.W. In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J. Virol. 1996, 70, 2774-2780.
151. Malmquist, W.A.; Van der Maaten, M.J.; Boothe, A.D. Isolation, immunodiffusion, immunofluorescence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle. Canc. Res. 1969, 29, 188-200.
152. Hatama, S.; Otake, K.; Ohta, M.; Kobayashi, M.; Imakawa, K.; Ikemoto, A.; Okuyama, H.; Mochizuki, M.; Miyazawa, T.; Tohya, Y.; et al. Reactivation of feline foamy virus from a chronically infected feline renal cell line by trichostatin a. Virology 2001, 283, 315-323.
153. Liebermann, H.; Riebe, R. Isolation of bovine syncytial virus in East Germany. Arch. Exp. Veterinarmed. 1981, 35, 917-919.
154. Ma, Z.; Hao, P.; Yao, X.; Liu, C.; Tan, J.; Liu, L.; Yang, R.; Geng, Y.; Chen, Q.; Qiao, W. Establishment of an indicator cell line to quantify bovine foamy virus infection. J. Basic Microbiol. 2008, 48, 278-283.
155. Yu, S.F.; Linial, M.L. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J. Virol. 1993, 67, 6618-6624.
156. von Laer, D.; Neumann-Haefelin, D.; Heeney, J.L.; Schweizer, M. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 1996, 221, 240-244.
157. Callahan, M.E.; Switzer, W.M.; Matthews, A.L.; Roberts, B.D.; Heneine, W.; Folks, T.M.; Sandstrom, P.A. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J. Virol. 1999, 73, 9619-9624.
158. German, A.C.; Harbour, D.A.; Helps, C.R.; Gruffydd-Jones, T.J. Is feline foamy virus really apathogenic? Vet. Immunol. Immunopathol. 2008, 123, 114-118.
159. Materniak, M.; Hechler, T.; Lochelt, M.; Kuzmak, J. Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep. J. Virol. 2013, 87, 3516-3525.
160. Bouillant, A.M.; Ruckerbauer, G.M. Isolation of bovine syncytial virus from lymphocytes recovered from fluids used to flush uterus and oviducts of superovulated cattle. Can. J. Comp. Med. 1984, 48, 332-334.
161. Scott, F.W.; Shively, J.N.; Gaskin, J.; Gillespie, J.H. Bovine syncytial virus isolations. Arch. Gesamte Virusforsch. 1973, 43, 43-52.
162. Van der Maaten, M.J.; Hubbert, W.T.; Boothe, A.D.; Bryner, J.H.; Estes, P.C. Isolations of bovine syncytial virus from maternal and fetal blood. Am. J. Vet. Res. 1973, 34, 341-343.
163. Greig, A.S. A syncytium regression test to detect antibodies to bovine syncytia virus. Can. J. Comp. Med. 1979, 43, 112-114.
164. Luther, P.D.; Nuttall, P.A.; Gibbons, R.A. Isolation of viruses from cultures of bovine endometrial cells. J. Infect. Dis. 1978, 138, 660-663.
165. Granzow, H.; Liebermann, H.; Riebe, R.; Solisch, P. Morphology and morphogenesis of bovine syncytial virus--electron microscopy of ultramicrotomic sections. Arch. Exp. Veterinarmed. 1981, 35, 791-800.
166. Falcone, V.; Leupold, J.; Clotten, J.; Urbanyi, E.; Herchenroder, O.; Spatz, W.; Volk, B.; Bohm, N.; Toniolo, A.; Neumann-Haefelin, D.; et al. Sites of simian foamy virus persistence in naturally infected african green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 1999, 257, 7-14.
167. Murray, S.M.; Picker, L.J.; Axthelm, M.K.; Linial, M.L. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J. Virol. 2006, 80, 663-670.
168. Materniak, M.H.T.; Löchelt, M.; Kuzmak, J. Seroreactivity of humans and ruminants to bovine foamy virus-Evidence for zoonotic transmission and existence of new reservoirs for foamy viruses. In Proceedings of the 8th International Foamy Virus Conference, Argos, Greece, 7-8 May 2010.
169. Nakamura, K.; Miyazawa, T.; Ikeda, Y.; Sato, E.; Nishimura, Y.; Nguyen, N.T.; Takahashi, E.; Mochizuki, M.; Mikami, T. Contrastive prevalence of feline retrovirus infections between northern and southern vietnam. J. Vet. Med. Sci. 2000, 62, 921-923.
170. Bandecchi, P.; Matteucci, D.; Baldinotti, F.; Guidi, G.; Abramo, F.; Tozzini, F.; Bendinelli, M. Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in italy. Vet. Immunol. Immunopathol. 1992, 31, 337-345.
171. Daniels, M.J.; Golder, M.C.; Jarrett, O.; MacDonald, D.W. Feline viruses in wildcats from scotland. J. Wildl. Dis. 1999, 35, 121-124.
172. Glaus, T.; Hofmann-Lehmann, R.; Greene, C.; Glaus, B.; Wolfensberger, C.; Lutz, H. Seroprevalence of bartonella henselae infection and correlation with disease status in cats in switzerland. J. Clin. Microbiol. 1997, 35, 2883-2885.
173. Winkler, I.G.; Lochelt, M.; Flower, R.L. Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: A seroepidemiological study. J. Clin. Microbiol. 1999, 37, 2848-2851.
174. Miyazawa, T.; Ikeda, Y.; Maeda, K.; Horimoto, T.; Tohya, Y.; Mochizuki, M.; Vu, D.; Vu, G.D.; Cu, D.X.; Ono, K.; et al. Seroepidemiological survey of feline retrovirus infections in domestic and leopard cats in northern vietnam in 1997. J. Vet. Med. Sci. 1998, 60, 1273-1275.
175. Bleiholder, A.; Muhle, M.; Hechler, T.; Bevins, S.; vandeWoude, S.; Denner, J.; Lochelt, M. Pattern of seroreactivity against feline foamy virus proteins in domestic cats from germany. Vet. Immunol. Immunopathol. 2011, 143, 292-300.
176. Löchelt, M.; Bleiholder, A. DKFZ, Heidelberg, Baden-Württemberg, Germany. Personal communication, 2013.
177. Jacobs, R.M.; Pollari, F.L.; McNab, W.B.; Jefferson, B. A serological survey of bovine syncytial virus in ontario: Associations with bovine leukemia and immunodeficiency-like viruses, production records, and management practices. Can. J. Vet. Res. 1995, 59, 271-278.
178. Johnson, R.H.; de la Rosa, J.; Abher, I.; Kertayadnya, I.G.; Entwistle, K.W.; Fordyce, G.; Holroyd, R.G. Epidemiological studies of bovine spumavirus. Vet. Microbiol. 1988, 16, 25-33.
179. Pamba, R.; Jeronimo, C.; Archambault, D. Detection of bovine retrospumavirus by the polymerase chain reaction. J. Virol. Meth. 1999, 78, 199-208.
180. Romen, F.; Backes, P.; Materniak, M.; Sting, R.; Vahlenkamp, T.W.; Riebe, R.; Pawlita, M.; Kuzmak, J.; Lochelt, M. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 2007, 364, 123-131.
181. Materniak, M. National Veterinary Research Institute, Pulawy, Poland. Unpublished work, 2007.
182. Materniak, M.; Kuzmak, J. Occurrence of equine foamy virus infection in horses from poland. In Proceedings of the 9th International Foamy Virus Conference, Bethesda, MD, USA, 29-30 May 2012.
183. Nasimuzzaman, M.; Persons, D.A. Cell membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol. Ther. 2012, 20, 1158-1166.
184. Plochmann, K.; Horn, A.; Gschmack, E.; Armbruster, N.; Krieg, J.; Wiktorowicz, T.; Weber, C.; Stirnnagel, K.; Lindemann, D.; Rethwilm, A.; et al. Heparan sulfate is an attachment factor for foamy virus entry. J. Virol. 2012, 86, 10028-10035.
185. Calattini, S.; Wanert, F.; Thierry, B.; Schmitt, C.; Bassot, S.; Saib, A.; Herrenschmidt, N.; Gessain, A. Modes of transmission and genetic diversity of foamy viruses in a macaca tonkeana colony. Retrovirology 2006, 3, 23.
186. Alke, A.; Schwantes, A.; Zemba, M.; Flugel, R.M.; Lochelt, M. Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus. Virology 2000, 275, 170-176.
187. Leendertz, F.H.; Zirkel, F.; Couacy-Hymann, E.; Ellerbrok, H.; Morozov, V.A.; Pauli, G.; Hedemann, C.; Formenty, P.; Jensen, S.A.; Boesch, C.; et al. Interspecies transmission of simian foamy virus in a natural predator-prey system. J. Virol. 2008, 82, 7741-7744.
188. Liu, W.; Worobey, M.; Li, Y.; Keele, B.F.; Bibollet-Ruche, F.; Guo, Y.; Goepfert, P.A.; Santiago, M.L.; Ndjango, J.B.; Neel, C.; et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog. 2008, 4, e1000097.
189. Goffe, A.S.; Blasse, A.; Mundry, R.; Leendertz, F.H.; Calvignac-Spencer, S. Detection of retroviral super-infection from non-invasive samples. PLoS One 2012, 7, e36570.
190. Galvin, T.A.; Ahmed, I.A.; Shahabuddin, M.; Bryan, T.; Khan, A.S. Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from macaca cyclopis (sfvmcy-2). J. Virol. 2013, 87, 8792-8797.
191. Choudhary, A.; Galvin, T.A.; Williams, D.K.; Beren, J.; Bryant, M.A.; Khan, A.S. Influence of naturally occurring simian foamy viruses (sfvs) on siv disease progression in the rhesus macaque (macaca mulatta) model. Viruses 2013, 5, 1414-1430.
192. Amborski, G.F.; Storz, J.; Keney, D.; Lo, J.; McChesney, A.E. Isolation of a retrovirus from the american bison and its relation to bovine retroviruses. J. Wildl. Dis. 1987, 23, 7-11.
193. Mochizuki, M.; Akuzawa, M.; Nagatomo, H. Serological survey of the iriomote cat (felis iriomotensis) in Japan. J. Wildl. Dis. 1990, 26, 236-245.
194. Mouinga-Ondeme, A.; Caron, M.; Nkoghe, D.; Telfer, P.; Marx, P.; Saib, A.; Leroy, E.; Gonzalez, J.P.; Gessain, A.; Kazanji, M. Cross-species transmission of simian foamy virus to humans in rural gabon, Central Africa. J. Virol. 2012, 86, 1255-1260.
195. Wolfe, N.D.; Switzer, W.M.; Carr, J.K.; Bhullar, V.B.; Shanmugam, V.; Tamoufe, U.; Prosser, A.T.; Torimiro, J.N.; Wright, A.; Mpoudi-Ngole, E.; et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 2004, 363, 932-937.
196. Betsem, E.; Rua, R.; Tortevoye, P.; Froment, A.; Gessain, A. Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog. 2011, 7, e1002306.
197. Heneine, W.; Switzer, W.M.; Sandstrom, P.; Brown, J.; Vedapuri, S.; Schable, C.A.; Khan, A.S.; Lerche, N.W.; Schweizer, M.; Neumann-Haefelin, D.; et al. Identification of a human population infected with simian foamy viruses. Nat. Med. 1998, 4, 403-407.
198. Boneva, R.S.; Switzer, W.M.; Spira, T.J.; Bhullar, V.B.; Shanmugam, V.; Cong, M.E.; Lam, L.; Heneine, W.; Folks, T.M.; Chapman, L.E. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res. Hum. Retrovir. 2007, 23, 1330-1337.
199. Butera, S.T.; Brown, J.; Callahan, M.E.; Owen, S.M.; Matthews, A.L.; Weigner, D.D.; Chapman, L.E.; Sandstrom, P.A. Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses. J. Am. Vet. Med. Assoc. 2000, 217, 1475-1479.
200. Winkler, I.G.; Lochelt, M.; Levesque, J.P.; Bodem, J.; Flugel, R.M.; Flower, R.L. A rapid streptavidin-capture elisa specific for the detection of antibodies to feline foamy virus. J. Immunol. Meth. 1997, 207, 69-77.
201. Hooks, J.J.; Burns, W.; Hayashi, K.; Geis, S.; Notkins, A.L. Viral spread in the presence of neutralizing antibody: Mechanisms of persistence in foamy virus infection. Infect. Immun. 1976, 14, 1172-1178.
202. Hooks, J.J.; Gibbs, C.J. Jr. The foamy viruses. Bacteriol. Rev. 1975, 39, 169-185.
203. Muhle, M.; Bleiholder, A.; Kolb, S.; Hubner, J.; Lochelt, M.; Denner, J. Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening. Virology 2011, 412, 333-340.
204. Hussain, A.I.; Shanmugam, V.; Bhullar, V.B.; Beer, B.E.; Vallet, D.; Gautier-Hion, A.; Wolfe, N.D.; Karesh, W.B.; Kilbourn, A.M.; Tooze, Z.; et al. Screening for simian foamy virus infection by using a combined antigen western blot assay: Evidence for a wide distribution among old world primates and identification of four new divergent viruses. Virology 2003, 309, 248-257.
205. Calattini, S.; Nerrienet, E.; Mauclere, P.; Georges-Courbot, M.C.; Saib, A.; Gessain, A. Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from cameroon and gabon. J. Gen. Virol. 2004, 85, 3313-3317.
206. Rua, R.; Betsem, E.; Calattini, S.; Saib, A.; Gessain, A. Genetic characterization of simian foamy viruses infecting humans. J. Virol. 2012, 86, 13350-13359.
207. Schweizer, M.; Neumann-Haefelin, D. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 1995, 207, 577-582.
208. Lew, A.E.; Bock, R.E.; Miles, J.; Cuttell, L.B.; Steer, P.; Nadin-Davis, S.A. Sensitive and specific detection of bovine immunodeficiency virus and bovine syncytial virus by 5' taq nuclease assays with fluorescent 3' minor groove binder-DNA probes. J. Virol. Meth. 2004, 116, 1-9.
209. Materniak, M.; Sieradzki, Z.; Kuzmak, J. Detection of bovine foamy virus in milk and saliva of bfv seropositive cattle. Bull. Vet. Inst. Pulawy. 2010, 54, 461-465.